Berenberg analyst Kerry Holford raised the firm’s price target on GSK (GSK) to 1,660 GBp from 1,600 GBp and keeps a Hold rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Novo Nordisk Stock (NVO) Jumps after Ozempic and Wegovy Prices Cut 71% under Medicare Plan
- FDA approves reformulated ranitidine tablets
- GSK upgraded to Neutral from Underperform at BofA
- GlaxoSmithKline’s Mixed Outlook: Balancing Product Launches and Patent Challenges
- RFK told CDC to change website language on autism and vaccines, NYT reports